← Leaderboards

Effie W Petersdorf

Fred Hutchinson Cancer Research Center

Google Scholar ↗PubMed ↗ORCID ↗

$50,293,518

Attributed

$50,622,588

Total exposure

12

Grants

7

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $3.9M · FY2005–25

$5M$3.8M$2.5M$1.3M$0

'05

'06

'07

'08

'09

'10

'11

'12

'13

'14

'15

'16

'17

'18

'19

'20

'21

'22

'23

'24

'25

Funding mix

By agency

NIH$50,622,588 · 12

By mechanism

U01$19,874,016 · 2

R01$17,295,845 · 3

P01$11,979,585 · 4

T32$658,140 · 1

R29$469,002 · 1

R21$346,000 · 1

Top collaborators

Nancy E Davidson1 shared

Most similar at Fred Hutchinson Cancer Research Center

Same institution · by research overlap

Daniel E Geraghty$19,850,502
Lue Ping Na Zhao$7,417,165

Others in their field

Top investigators on “Transplantation”

Gerald T Nepom · Benaroya Research Inst At Virginia Mason$298,740,071
Mary M Horowitz · Medical College Of Wisconsin$224,924,548
Craig B Thompson · Sloan-Kettering Inst Can Research$157,997,949
Charles A Coltman · Southwest Oncology Group$141,983,231
Richard L Schilsky · University Of Chicago$117,759,216
Harold E Varmus · Sloan-Kettering Institute For Cancer Res$82,854,111

Research focus

TransplantationHaplotypesVariantAllelesGenesHla-A GeneHematological DiseaseRelapseGeneticGenotypeDonor SelectionCaucasiansHematopoietic Cell TransplantationDonor PersonSuccessDisorder RiskSafetyImmunogeneticsTransplant RecipientsHigh RiskGraft-Vs-Host DiseaseMortalityBaseAcute Graft Versus Host Disease

Grant awards (89)

Clinical Significance of MHC Haplotypes in HCT$1,312,560

R01 · FY2025 · CA · contact PI

Hematopoietic Stem Cell And Cord Blood Transplantation$725,390

U01 · FY2025 · AI · contact PI

Training in cancer biology and transplantation$658,140

T32 · FY2025 · CA

Immuno and Epigenetics of Hematopoietic Cell Transplantation$657,662

R01 · FY2025 · CA · contact PI

Immunogenetics of Outcomes Disparities After Allogeneic HCT$442,969

R01 · FY2025 · CA · contact PI

Hematopoietic Stem Cell And Cord Blood Transplantation$851,183

U01 · FY2024 · AI · contact PI

Immuno and Epigenetics of Hematopoietic Cell Transplantation$616,280

R01 · FY2024 · CA · contact PI

Immunogenetics of Outcomes Disparities After Allogeneic HCT$424,151

R01 · FY2024 · CA · contact PI

Clinical Significance of MHC Haplotypes in HCT$421,457

R01 · FY2024 · CA · contact PI

Hematopoietic Stem Cell And Cord Blood Transplantation$820,502

U01 · FY2023 · AI · contact PI

Immuno and Epigenetics of Hematopoietic Cell Transplantation$623,084

R01 · FY2023 · CA · contact PI

Clinical Significance of MHC Haplotypes in HCT$443,638

R01 · FY2023 · CA · contact PI

Immunogenetics of Outcomes Disparities After Allogeneic HCT$442,860

R01 · FY2023 · CA · contact PI

Hematopoietic Stem Cell And Cord Blood Transplantation$729,767

U01 · FY2022 · AI · contact PI

Immunogenetics of Outcomes Disparities after Allogeneic HCT$394,548

R01 · FY2022 · CA · contact PI

Clinical Significance of MHC Haplotypes in HCT$362,052

R01 · FY2022 · CA · contact PI

Hematopoietic Stem Cell And Cord Blood Transplantation$743,524

U01 · FY2021 · AI · contact PI

Immuno and Epigenetics of Hematopoietic Cell Transplantation$387,519

R01 · FY2021 · CA · contact PI

Immunogenetics of Outcomes Disparities after Allogeneic HCT$293,484

R01 · FY2021 · CA · contact PI

Clinical Significance of MHC Haplotypes in HCT$227,652

R01 · FY2021 · CA · contact PI

Immuno and Epigenetics of Hematopoietic Cell Transplantation$196,434

R01 · FY2021 · CA · contact PI

Clinical Significance of MHC Haplotypes in HCT$147,713

R01 · FY2021 · CA · contact PI

Immunogenetics of Outcomes Disparities after Allogeneic HCT$93,208

R01 · FY2021 · CA · contact PI

Hematopoietic Stem Cell And Cord Blood Transplantation$42,304

U01 · FY2021 · AI · contact PI

Hematopoietic Stem Cell And Cord Blood Transplantation$808,331

U01 · FY2020 · AI · contact PI

Immuno and Epigenetics of Hematopoietic Cell Transplantation$598,504

R01 · FY2020 · CA · contact PI

Immunogenetics of Outcomes Disparities after Allogeneic HCT$390,800

R01 · FY2020 · CA · contact PI

Clinical Significance of MHC Haplotypes in HCT$382,161

R01 · FY2020 · CA · contact PI

Hematopoietic Stem Cell and Cord Blood Transplantation$752,565

U01 · FY2019 · AI · contact PI

Immuno and Epigenetics of Hematopoietic Cell Transplantation$581,160

R01 · FY2019 · CA · contact PI

Immunogenetics of Outcomes Disparities after Allogeneic HCT$390,521

R01 · FY2019 · CA · contact PI

Clinical Significance of MHC Haplotypes in HCT$364,913

R01 · FY2019 · CA · contact PI

Hematopoietic Stem Cell and Cord Blood Transplantation$717,187

U01 · FY2018 · AI · contact PI

Immuno and Epigenetics of Hematopoietic Cell Transplantation$630,020

R01 · FY2018 · CA · contact PI

Immunogenetics of Outcomes Disparities after Allogeneic HCT$409,042

R01 · FY2018 · CA · contact PI

Clinical Significance of MHC Haplotypes in HCT$376,200

R01 · FY2018 · CA · contact PI

Hematopoietic Stem Cell and Cord Blood Transplantation$755,861

U01 · FY2017 · AI · contact PI

Immuno and Epigenetics of Hematopoietic Cell Transplantation$660,012

R01 · FY2017 · CA · contact PI

Clinical Significance of MHC Haplotypes in HCT$335,005

R01 · FY2017 · CA · contact PI

Immunogenetics of Graft-Versus-Host Disease$2,098,949

P01 · FY2016 · CA · contact PI

Hematopoietic Stem Cell and Cord Blood Transplantation$822,437

U01 · FY2016 · AI · contact PI

Clinical Significance of MHC Haplotypes in HCT$334,986

R01 · FY2016 · CA · contact PI

Immunogenetics of Graft-Versus-Host Disease$2,098,949

P01 · FY2015 · CA · contact PI

Hematopoietic Stem Cell and Cord Blood Transplantation$952,157

U01 · FY2015 · AI · contact PI

Clinical Significance of MHC Haplotypes in HCT$334,967

R01 · FY2015 · CA · contact PI

Genetic Mechanisms of Survivorship Disparities after Unrelated HCT$329,742

U01 · FY2015 · CA · contact PI

Immunogenetics of Graft-Versus-Host Disease$2,035,982

P01 · FY2014 · CA · contact PI

Hematopoietic Stem Cell and Cord Blood Transplantation$936,216

U01 · FY2014 · AI · contact PI

Genetic Mechanisms of Survivorship Disparities after Unrelated HCT$340,670

U01 · FY2014 · CA · contact PI

Clinical Significance of MHC Haplotypes in HCT$324,901

R01 · FY2014 · CA · contact PI

Immunogenetics of Graft-Versus-Host Disease$1,973,012

P01 · FY2013 · CA · contact PI

Hematopoietic Stem Cell and Cord Blood Transplantation$873,791

U01 · FY2013 · AI · contact PI

Clinical Significance of MHC Haplotypes in HCT$336,873

R01 · FY2013 · CA · contact PI

Genetic Mechanisms of Survivorship Disparities after Unrelated HCT$300,729

U01 · FY2013 · CA · contact PI

Immunogenetics of Graft-Versus-Host Disease$2,098,949

P01 · FY2012 · CA · contact PI

Hematopoietic Stem Cell and Cord Blood Transplantation$1,182,826

U01 · FY2012 · AI · contact PI

Clinical Significance of MHC Haplotypes in HCT$334,184

R01 · FY2012 · CA · contact PI

Genetic Mechanisms of Survivorship Disparities after Unrelated HCT$331,591

U01 · FY2012 · CA · contact PI

Hematopoietic Stem Cell and Cord Blood Transplantation$1,130,940

U01 · FY2011 · AI · contact PI

Immunogenetics of Graft-Versus-Host Disease$379,587

P01 · FY2011 · CA · contact PI

Genetic Mechanisms of Survivorship Disparities after Unrelated HCT$370,000

U01 · FY2011 · CA · contact PI

Clinical Significance of MHC Haplotypes in HCT$334,184

R01 · FY2011 · CA · contact PI

Hematopoietic Stem Cell and Cord Blood Transplantation$1,058,211

U01 · FY2010 · AI · contact PI

Clinical Significance of MHC Haplotypes in HCT$344,520

R01 · FY2010 · CA · contact PI

Immunogenetics of Graft-Versus-Host Disease$280,774

P01 · FY2010 · CA · contact PI

Hematopopietic Stem Cell Transplantation$671,389

U01 · FY2009 · AI · contact PI

Hematopopietic Stem Cell Transplantation$637,185

U01 · FY2009 · AI · contact PI

Immunogenetics of Graft-Versus-Host Disease$357,094

P01 · FY2009 · CA · contact PI

Clinical Significance of MHC Haplotypes in HCT$344,520

R01 · FY2009 · CA · contact PI

Hematopopietic Stem Cell Transplantation$1,335,314

U01 · FY2008 · AI · contact PI

Immunogenetics of Graft-Versus-Host Disease$349,382

P01 · FY2008 · CA · contact PI

Clinical Significance of MHC Haplotypes in HCT$344,520

R01 · FY2008 · CA · contact PI

Hematopopietic Stem Cell Transplantation$647,075

U01 · FY2007 · AI · contact PI

Clinical Significance of MHC Haplotypes in Hematopoietic Cell Transplantation$318,037

R01 · FY2007 · CA · contact PI

Immunogenetics of Graft-Versus-Host Disease$306,907

P01 · FY2007 · CA · contact PI

Hematopopietic Stem Cell Transplantation$659,040

U01 · FY2006 · AI · contact PI

Clinical Significance of MHC Haplotypes in HCT$326,363

R01 · FY2006 · CA · contact PI

Hematopoietic Stem Cell Transplantation$348,089

U01 · FY2005 · AI

Clinical Significance of MHC Haplotypes in HCT$331,702

R01 · FY2005 · CA

Clinical Significance of MHC Haplotypes in HCT$334,891

R01 · FY2004 · CA

SNPs in Lung Cancer Risk and Therapeutic Response$173,000

R21 · FY2004 · CA

Clinical Significance of MHC Haplotypes in HCT$345,588

R01 · FY2003 · CA

SNPs in Lung Cancer Risk and Therapeutic Response$173,000

R21 · FY2003 · CA

OPTIMIZING BMT FOR CANCER BY GENETIC MATCHING OF DONORS$120,648

R29 · FY2003 · CA

OPTIMIZING BMT FOR CANCER BY GENETIC MATCHING OF DONORS$117,135

R29 · FY2002 · CA

Functional Genomic Markers in Stem Cell Transplantation$0

P01 · FY2002 · AI

Immune Deviation or Tolerance Induced by Human Lymphoid Dendritic$0

P01 · FY2002 · AI

OPTIMIZING BMT FOR CANCER BY GENETIC MATCHING OF DONORS$113,723

R29 · FY2001 · CA

OPTIMIZING BMT FOR CANCER BY GENETIC MATCHING OF DONORS$117,496

R29 · FY2000 · CA